Post Capsule Endoscopy Small Bowel Cancer Rate-An Australian Data Linkage Analysis.

ABSTRACT:

Purpose

Small bowel (SB) capsule endoscopy (CE) is a well-established investigation for suspected SB pathology, but little research has evaluated the diagnostic miss rate of SB cancer. This Australian study sought to assess the risk of developing SB cancer within 36 months of a cancer-negative CE (PCSBC-3Y) using a novel root-cause analysis (RCA) method.

Methods

Using a prospective CE database and data linkage with a population-based state cancer registry, the PCSBC-3Y rate was evaluated in consecutive patients undergoing CE between 2007 and 2019. SB cancers diagnosed or suspected from CE were defined as 'detected cancers', whilst those diagnosed within 36 months of a negative CE were defined as 'missed cancers'. Descriptive statistics summarised characteristics for all diag

SUBMITTER: Hoey P 

PROVIDER: S-EPMC12450118 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature